Loading...
Sharps Technology, Inc.
STSSW•NASDAQ
Financial ServicesFinancial - Capital Markets
$0.01
$0.001(10.45%)
Sharps Technology, Inc. (STSSW) Stock Overview
Explore Sharps Technology, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for STSSWStats details for STSSW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for STSSWAnalyst Recommendations details for STSSW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
CEO
Mr. Robert M. Hayes
Employees
55
Headquarters
105 Maxess Road, Melville, NY
Founded
2022